AFIB Acutus Medical


Data from SEC filings
Employee count

ESG framework mentions

In last year of SEC filings
Sustainability Accounting Standards Board (SASB)
No mentions
Global Reporting Initiative (GRI)
No mentions
Task Force on Climate-related Financial Disclosures (TCFD)
No mentions
UN Sustainable Development Goals (SDGs)
No mentions

Shareholder alignment

Proxy contests and exempt solicitations in last 3 years

No recent proxy contest or exempt solicitation filings from shareholders.

Vote support at last AGM

On June 17, 2021, Acutus Medical, Inc. (the “Company”) held its Annual Meeting of Stockholders (the “Annual Meeting”). The Company’s definitive proxy statement for the Annual Meeting was filed with the U.S. Securities and Exchange Commission (the “SEC”) on April 29, 2021 and describes in detail both of the two proposed voting matters (the “Proposals”) submitted to the Company’s stockholders at the Annual Meeting. The final results for the votes cast with respect to each Proposal, rounded to the nearest whole share, are set forth below.

As of April 19, 2021, the record date of the Annual Meeting, there were 28,123,261 outstanding shares of the Company’s common stock. At the Annual Meeting, a quorum of 24,560,912 shares of the Company’s common stock were represented in person or by proxy.

Proposal 1

The stockholders elected each of Vince Burgess, Shahzad Malik and John Sheridan, as a Class I director to hold office until the 2024 Annual Meeting of Stockholders, and in each case until their respective successors are duly elected and qualified, by the following vote:

NomineeVotes ForVotes AgainstAbstentionsBroker Non-Votes
Vince Burgess20,459,80601,405,1282,695,978
Shahzad Malik, MB BChir18,129,81503,735,1192,695,978
John Sheridan21,838,891026,0432,695,978

Proposal 2

The stockholders ratified the appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021 by the following vote:

Votes ForVotes AgainstAbstentions

No other items were presented for stockholder approval at the Annual Meeting.